Interestingly, afatinib treatment revealed a significant, durable response to CC and NSCLC patients with NRG1 fusion proteins such as ATP1B1-NRK1 and SDC4-NRG1 [151]. The gene discussed is NRG1; the disease is non-small cell lung carcinoma.